Abstract. We have examined the properties and intra-
M
EMBRANE proteins follow a common path of assembly and transport to the cell surface (reviewed in Burgess and Kelly, 1987; Pfeffer and Rothman, 1987) . They are synthesized, glycosylated and assembled in the ER, transported to the Golgi apparatus where N-linked oligosaccharides are processed and other modifications made, and then transported to the cell surface. Proteins may deviate from this pathway under a variety of circumstances. Misfolding of the protein or failure to assemble can result in retention in the ER (Doyle et al., 1985 (Doyle et al., , 1986 Copeland et al., 1986 Copeland et al., , 1988 Gething et al., 1986; Kreis and Lodish, 1986; Salter and Cresswell, 1986; Doms et al., 1988; Chen et al., 1988) . Experimental manipulations such as change in pH, reduced temperature, or the addition of ionophores can also disrupt the movement of proteins to the surface, resulting in their intracellular retention (Matlin et al., 1988; Strous et al., 1985; Matlin, 1986; Griffiths et al., 1983; Matlin and Simons, 1983; Saraste and Kuismanen, 1984) . These deviations from the normal pathway are useful for its dissection and for attempts to understand its regulation.
The nicotinic acetylcholine receptor (AChR)' is an oligomeric membrane protein expressed in differentiated muscle cells that follows a pathway to the cell surface resembling that of other membrane proteins (Anderson and Blobel, 1981, Roy A. Black's present address is Immunex Corp., 51 University Street, Seattle, WA 98101.
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1983; Merlie et al., 1983; Carlin and Merlie, 1987) . The receptor is assembled in the ER from four highly homologous glycosylated subunits to form the structure c~2fl3,6 (Smith et al., 1987) . It is then transported to the Golgi apparatus (Fambrough and Devreotes, 1978) , where some of the oligosaccharides on the 3' and 6 subunits are processed to complex forms (Gu and Hall, 1988b) , and the fully processed AChR is then transported to the cell surface (Devreotes et al., 1977; Merlie et al., 1983) .
We have recently investigated a genetic variant of the C2 mouse muscle cell line, T-, that expresses a reduced amount of AChR on its surface (Black and Hall, 1985) . Previous experiments (Gu et al., 1989) have shown that, although the T-variant synthesizes a normal amount of receptor, only a small fraction of the assembled AChR reaches the cell surface. The remainder is accumulated in the cell interior. Here we investigate the molecular properties and intracellular location of the AChR in wild-type and variant C2 myotubes to determine the point in the intracellular pathway to the surface at which the AChR in variant cells has been retained or diverted.
recognize the ~ and 6 subunit, respectively (Gu and Hall, 1988a,b) , were prepared as described in Gu and Hall (1988a) ; anti-BiP (immunoglobulin heavy chain-binding protein) monoclonal antibody (Bole et al., 1986) was the generous gift of Dr. David Bole (Yale University, New Haven, CT); anti-Golgi monoclonal antibody (Allan and Kreis, 1986) was kindly provided by Dr. V. Allan (University of California, San Francisco, CA); and a polyclonal antiserum raised against the Japanese strain of influenza virus was the generous girl of Dr. Judith White (University of California, San Francisco, CA).
Cell Culture and Metabolic Labeling Conditions
The C2 mouse muscle cell line, isolated originally by Yaffe and Saxel (1977) , was maintained in DME H-16 supplemented with 20% FBS and 0.5 % chick embryo extract as described in Inestrosa et al. (1983) and Gu et al. (1985) . Differentiation of myoblasts into myotubes was stimulated by transferring cells into fusion medium (DME H-16 supplemented with 10% horse serum). Cells were usually used 3-4 d after transfer to fusion medium.
Metabolic labeling of C2 myotubes in culture was routinely carried out with [35S]methionine/cysteine (Tran 35S label; ICN Radiochemicals, Irvine, CA). To label AChRs, myotube cultures in 10-cm dishes were incubated with 1 mCi [35S]methionine/cysteine overnight in methionine/ cysteine-free DME H-16 supplemented with 2% horse serum. To label fibronectin, cells were incubated with labeled amino acids for 6 b under the same conditions. To pulse-label hemagglutinin produced by cells infected with influenza virus, infected cells in 60-ram dishes were washed with 2 ml methionine/cysteine-free medium and incubated for 15 rain. They were labeled with the same medium containing 0.5 mCi [35S]methionine/cysteine for 10 min at 37°C. Incorporation of radioactive amino acids was stopped by washing the cells with 5 ml PBS containing 2 mg/ml unlabeled methionine and cysteine; the cells were then chased in 5 ml fusion medium for the indicated time.
AChR Preparation and Western Blot Analysis
AChRs were isolated from C2 myotube cultures according to the procedure previously described (Gu and Hall, 1988b) . Myotubes were collected by scraping into PBS with a rubber policeman. The cell pellet obtained by centrifugation was then extracted with a buffer containing 50 mM Tris-HC1 (pH 7.4), 50 mM NaC1, 1% Triton X-100, 2 mM EDTA, 2 mM EGTA, 0.4 mM PMSE 1 mM N-ethylmaleimide (NEM), 1 mM sodium tetrathionate, 20 #g/ml leupeptin, 20 #g/ml pepstatin, 20 U/ml aprotinin (buffer A). For isolation of AChRs from metabolically labeled cultures, the extract was applied to an t~-cobratoxin-Sepharose column and the bound receptor eluted with 1 M carbamylcholine. Receptor was further purifed by immunoprecipitation with mAb 61, a monoclonal antibody that recognizes the a subunit of the receptor (Tzartos et al., 1981) . For endoglycosidase digestion and Western blot analysis, AChRs in extracts of unlabeled cells were adsorbed to a-bungarotoxin (u-BuTx) coupled to Sepharose and eluted by boiling in 0.6% SDS; they were then treated with endoglycosidase H (endo H) or endoglycosidase F (endo F). AChRs were routinely analyzed on 9% SDS polyacrylamide gels and, for Western blot analysis, transferred to nitrocellulose membranes and probed with subunit-specific antibodies as described in Gu and Hall (1988b) . In some experiments, receptors on the cell surface were separated from internal ones by incubating intact myotubes with unlabeled ot-BuTx, followed by extraction and immunoprecipitation with anti-a-BuTx antibodies.
Isolation of Fibronectin
Fibronectin was isolated from myotube culture medium according to the method of Ruoslahti et al. (1982) , using affinity chromatography on gelatinSepharose (Pharmacia Fine Chemicals, Piscataway, NJ) as the single purification step.
Expression and Isolation of Influenza Hemagglutinin
C2 myotubes were infected with the Japanese strain of influenza virus (generously given to us by Dr. Judith White, University of California, San Francisco, CA) according to the procedure described by Yewdell et al. (1988) . Confluent myotube cultures in 60-ram dishes were rinsed with 5 ml PBS and incubated at room temperature with 2 ml DME H-16 supplemented with 0.1% BSA and 20 mM Hepes (pH 7.6) containing 400 hemagglutinin (HA) units of infectious influenza virus. 5 ml of DME supplemented with 10% horse serum were then added and the incubation continued for 6 h at 37°C. Cells were then washed with PBS and labeled with [35S]methionine/cysteine as described above. Pulse-chase labeled cells were collected by scraping them into PBS and the cell pellet obtained by centrifugation extracted in 50 mM Tris-HCI (pH 7.4), 1% Triton X-100, 2 mM EDTA, 2 mM EGTA, 1 mM PMSE 20 U/ml aprotinin, 20 #g/ml soybean trypsin inhibitor. HA was isolated from the extract by immunoprecipitation with an antiserum raised against the influenza virus. Immunoprecipitates were washed with 1 M NaCl, 0.1% SDS, 0.1% Triton X-100, 50 mM Tris, pH 7.4 and eluted by boiling in 0.6% SDS.
Endo H and Endo F Digestion
Endoglycosidase digestion of isolated proteins was carried out as previously described (Gu and Hall, 1988b) . For digestion of the AChR, the digestion mixture contained 0.2% SDS, 20 mM sodium citrate (pH 5.5), 10 mM EDTA, and 10 mU/ml endo H (Boehringer Mannheim Biochemicals, Indianapolis, IN) or 4 U/ml endo F (New England Nuclear, Boston, MA); for digestion of fibronectin and HA, the reaction mixture also contained 0.1 M ~-mercaptoethanol. The reaction was carried out at 37°C for 15-18 h and was stopped by boiling in SDS-PAGE sample buffer.
Subcellular Fractionation of C2 Myotubes
Subcellular fractionation of C2 myotubes were carried out as described by Smith et al. (1987) for BC3H-I cells. Wild-type or T-myotube cultures in 10-cm dishes were rinsed twice with TBS (25 mM Tris-HCI, pH 7.4, 144 mM NaCI) and collected in 0.7 ml homogenization buffer containing 2.7 % sucrose, 1 mM MgCl2, 5 mM K-Hepes, pH 7.5. The cells were then homogenized with seven strokes in a 7-ml Dounce homogenizer (Wheaton Instruments Div., Millville, N J). The homogenate was loaded on a 20-69% sucrose gradient and centrifuged in a rotor (Model SW 60; Beckman Instruments Inc., Palo Alto, CA) for 30 min at 60000 rpm as described in Smith et al. (1987) . 200 p,l fractions were then collected from the top of the gradient with a micropipct and each fraction assayed for AChR and for ER and Golgi markers.
Assays
The amount of AChR in sucrose gradient fractions was determined with the DEAE filtration assay described in Brockes and Hall (1975) . Aliquots of gradient samples were mixed with equal volumes of 2× concentrated buffer A and incubated with t25I-labeled a-BuTx (Amersham Corp., Arlington Heights, IL) for 2 h at 37°C. The reaction mixture was then applied to DEAE filters and bound receptor determined by counting in a gamma counter. Glucose-6-pbosphatase, UDP-galactose/N-acetylglucosamine galactosyltransferase, and rnannosidase II activities were measured according to the methods described in Smith et al. (1987) .
lmmunocytochemistry
For immunofluorescence, C2 cells were grown on round glass coverslips (gold seal, 1/4" diam) that were kept in 24-well plates. All solutions were prepared with PBS unless otherwise stated.
For staining of the intracellular AChR, the cells were incubated with 1 #M unlabeled t~-BuTx for 90 min to block surface AChR. They were then rinsed with PBS, fixed with 2% paraformaldehyde for 20 rain, permeabilized with 1% Triton X-100 for l0 rain, and stained for 2 h with rhodamineconjugated a-bungarotoxin (rho-~-BuTx) in PBS containing 1% BSA (PBS/BSA). They were rinsed again and mounted in glycerol supplemented with para-phenylenediamine (Platt and Michael, 1983) .
For staining of the Golgi apparatus, cells were fixed as described above and permeabilized with 0.1% Triton X-100/0.5% SDS in PBS. They were incubated for 15 min in 10% FCS/4% BSA to block nonspecific binding and then for 2 h with an anti-Golgi monoclonal antibody diluted in the same buffer. This antibody recognizes a 110-kD Golgi protein and shows a pattern of staining that is very similar to that obtained with classical Golgi markers (Allan and Kreis, 1986) . Finally, the cells were incubated with a fluoresceinconjugated goat anti-mouse antibody (Cappel Laboratories, Malveru, PA) in PBS/BSA, rinsed and mounted as described above.
For staining of the ER, cells were handled as described in the previous section, except that permeabilization was with 1% Triton X-100 and the blocking step was omitted. An anti-immunoglobulin heavy chain-binding protein (BiP) rat monoclonal antibody (Bole et al., 1986 ) was applied for 2 h in PBS/BSA, followed by fluorescein-conjugated goat anti-rat antibodies. Figure 1 . Subunit composition of AChRs in wild-type and Tvariant cells. Wild-type (Wt) or T-myotube cultures were metabolically labeled overnight with [35S]methionine/ cysteine. The cells were then collected and extracted and AChRs isolated from the extract by affinity chromatography on an a-cobratoxin-Sepharose column, followed by immunoprecipitation with mAb 61 as described in Materials and Methods. Immunoprecipitams were analyzed on 9% SDS polyacrylamide gels under reducing conditions and fluorographed. The figure shows an autoradiograph of the gel. Note that the mobilities of the bands tentatively identified as the 3' and t5 subunits of the receptor are different in wild-type and T-cells.
were used: endo H, which recognizes N-linked oligosaccharides with five or more mannose residues (high-mannose oligosaccharides) (Tarentino et al., 1978) , and endo F, which cleaves all types of N-linked oligosaccharides, including both high-mannose and complex type oligosaccharides (Elder and Alexander, 1982) .
The results of the immunoblotting experiment confirmed and extended those of the metabolic labeling experiment.
Results

T-A C h R H a s A b n o r m a l N -l i n k e d Oligosaccharides
To compare the subunit structures of the AChR in wild-type and T-myotubes, we labeled myotube cultures overnight with [35S]methionine/cysteine and purified the AChR by affinity chromatography on cobratoxin-Sepharose column, followed by immunoprecipitation with mAb 61, a monoclonal antibody that recognizes the t~ subunit (Tzartos et al., 1981 ). The purified AChRs were then analyzed by SDS-PAGE and fluorography. Four bands were detected in each preparation ( Fig. 1 ). All appeared to be subunits of the AChR as they were not present in a control preparation in which the myotube extracts were incubated with a-BuTx before the cobratoxin-Sepharose purification step (data not shown). The two bands of lower apparent molecular weights corresponded to the previously identified t~ and/3 subunits of the receptor, respectively (Black et al., 1987) , and had identical mobilities for wild-type and T-myotubes. The other two bands, which were tentatively identified as the 3, and ~ subunits, both showed slightly increased mobilities in the T-AChR relative to the wild-type AChR (Fig. 1) , suggesting that the and ~ subunits in T-cells are different from those in wildtype cells. As two of the subunits have altered mobilities, a difference in covalent modification of the subunits, such as glycosylation, is more likely than a difference in peptide backbone.
To identify the AChR subunits unequivocally and to characterize further the difference between the two AChR preparations, AChRs from wild-type or T-myotubes were partially purified by affinity chromatography on an a-BuTxSepharose column, subjected to SDS-PAGE, and analyzed by immunoblotting using antibodies specific for each of the four subunits of the muscle AChR (Gu and Hall, 1988a,b) . Samples of the AChRs from wild-type and T-myotubes were treated with glycosidases before immunoblotting to test for changes in N-linked glycosylation. Two glycosidases Figure 2 . N-linked glycosylation of AChR in wild-type and T-C2 myotuhes. AChRs partially purified from wild-type control (lanes C, lanes 1, 3, and 5) or T-variant (lanes V, lanes 2, 4, and 6) myotubes by affnity chromatography on t~-BuTx-Sepharose column were either mock digested (lanes 1 and 2), digested with endo H (lanes 3 and 4), or endo F (lanes 5 and 6) for 16 h at 37°C under conditions described in Materials and Methods. They were then subjected to reducing SDS-PAGE and immunoblotting analysis. Antibodies used as probes were (a) mAb 14-3-F-7 to detect c~ subunit, (b) mAb 124 to detect/3 subunit, (c) anti-3" 485 antibodies to detect 3, subunit or (d) anti-6 486 antibodies to detect 6 subunit. The mobilities of the single a band, identified with mAb 14-3-F7 (Dowding and Hall, 1987) , were identical in wild-type and T-AChR preparations (Fig. 2 a, lanes 1 and 2) . Treatment with endo H increased the mobilities of the c~ subunits equally in both preparations (Fig. 2 a, lanes 3 and 4) . Treatment with endo F also increased the mobilities of the c~ subunits, and to the same extent as did endo H (Fig. 2 a,  lanes 5 and 6) . Thus, no difference was detected between wild-type and T-a subunit either with or without endoglycosidase treatment. We conclude that the a subunit of the C2 AChR, like that of the rat muscle and Torpedo AChRs (Gu and Hall, 1988b; Nomoto et al. 1986 ), contains only high-mannose oligosaccharides and that the c~ subunits are indistinguishable in the AChRs of wild-type and T-myotubes.
Similar results were obtained for the/~ subunit (Fig. 2 b) . The /3 subunit, detected by mAb 124 (Gullick and Lindstrom, 1983 ), appears to contain only endo H-sensitive, high-mannose N-linked oligosaccharide residues, and no difference was found between wild-type and T-AChR. In the case of the ~ subunit, the product of endo F digestion had a slightly higher apparent molecular weight than the product of endo H digestion (Fig. 2 b, compare lanes 3 and 4 with lanes 5 and 6), as was seen with the ~ subunit of rat muscle AChR (Gu and Hall, 1988b ) and with influenza virus HA protein (see Fig. 4 ). The reason for this is unknown.
Different results were obtained for the 3' and 6 subunits. First, two bands were observed for each subunit (Fig. 2, c  and d ). This pattern is similar to that seen on Western blots of the 3' and ~5 subunits of rat muscle AChR under similar conditions, and is apparently due to proteolysis (Gu and Hall, 1988b) . Second, as was found in the metabolic labeling experiment, the mobilities of both 3' and ~5 subunits were increased in the T-AChR compared to that of wild-type AChR (Fig. 2, c and d, lanes 1 and 2 in both) . In each case, this difference was abolished by endo F treatment (Fig. 2, c and  d, lanes 5 and 6 in both) . Thus the difference in the electrophoretic mobilities of the 3' and ~5 subunits in wild-type and T-AChRs arises from a difference in N-linked glycosylation.
Further, a comparison of the products of endo H and endo F digestions shows that in the AChRs of wild-type cells, both 3' and ~5 subunits have a mixture of endo H-sensitive (highmannose) and endo H-resistant (complex) oligosaccharides. The 3' and ~5 subunits from the T-AChRs, in contrast, have only endo H-sensitive, high-mannose oligosaccharides. In the wild-type AChR, endo H treatment produced a small shift in the mobility of the 3' subunit, and endo F treatment produced a larger shift (Fig. 2 c, lanes 1, 3, and 5) , whereas in the case of the T-AChR, both endo H and endo F treatment produced the same shift in the 3" subunit mobility (Fig.  2 c, lanes 2, 4, and 6 ). Similar results were obtained for the ~5 subunit. Thus, the oligosaccharides in the 3' and 5 subunits in the T-variant are defective in that they are not processed to complex, endo H-resistant forms as they are in wild-type cells.
Other Proteins in the 7"-Variant Are Normally Glycosylated
The failure of T-myotubes to process high-mannose oligosaccharides on the 3, and 6 chains of the AChR to complex forms could either be a general defect that affects all glycoproteins or one that is specific to the AChR. Two experimental approaches were taken to distinguish these possibilities. First, we compared the pattern of sensitivity of wild-type and T-variant cells to various lectins, a technique commonly used to detect defects in glycosylation of surface proteins in other types of variant cell lines (Stanley, 1984; Kingsley et al., 1986) . No significant differences were seen in the pattern of susceptibility of the two cell types to wheat germ agglutinin, ricin, and concanavalin A (data not shown), suggesting that T-cells do not have a general defect in glycosylation of surface proteins.
Next we examined the N-linked glycosylation of two specific proteins, fibronectin, an endogenous extracellular matrix protein that is secreted into the medium of myocytes, and influenza virus HA protein, a foreign membrane protein that is expressed on the surface of cells infected with influenza virus. Fibronectin was isolated from the media of wildtype or T-myotube cultures that had been labeled with pS]methionine and cysteine for 6 h. In preparations from both wild-type and T-cultures, endo H produced little or no shift in the electrophoretic mobility of fibronectin (Fig. 3 , lanes 2), while endo F treatment produced a distinct shift (Fig. 3, lanes 3) . No difference was observed under any condition in the mobilities of fibronectin in wild-type and Tcells.
The fibronectin preparation obtained from T-cultures also contained a protein of 135,000 Mr that was not detectable in wild-type cultures (Fig. 3) . Although we do not know the identity of this protein, its behavior after glycosidase treatment clearly indicated that it also contained endo H-resistant oligosaccharides.
Similar results were also obtained with influenza HA protein expressed in wild type and T-cultures after infection with influenza virus. In both cases, HA proteins remained endo H-sensitive shortly after synthesis (Fig. 4 A) , but be- 1-3) or T-(lanes 4-6) myotube cultures were infected with influenza virus and pulse labeled with [35S]methionine/cysteine for 10 min as described in Materials and Methods. Cell extracts were then prepared either immediately after the pulse (A) or after a 60-min chase in the presence of excess unlabeled amino acids (B) and immunoprecipitated with an antiserum raised against the virus. Immunoprecipitates were either mockdigested (lanes 1 and 4), digested with endo H (lanes 2 and 5), or endo F (lanes 3 and 6), analyzed on 9% SDS polyacrylamide gels under reducing conditions, and fluorographed. Control experiments showed that all the HA protein was intracellular at the end of the pulse and that ~50% reached the cell surface during the 60-min chase in both cell types.
came endo H-resistant after a 60-min chase (Fig. 4 B) . These results, taken together with those on fibronectin, indicate that T-cells are capable of producing complex N-linked sugars, and that the alteration in oligosaccharides on the 3" and 5 chains of the AChR is not a general defect.
Surface A C h R s in T-Cells Contain Normal N-linked Sugars
Are the oligosaccharides on the surface AChRs of T-cells sensitive to endo H? Surface AChRs were isolated from wildtype and T-myotubes by labeling intact myotubes with a-BuTx, followed by extraction and immunoprecipitation with anti-ot-BuTx antibodies. Immunoblots of the AChRs were then made using anti-3' 485 antibodies (Gu and Hall, 1988a,b) as the probe. The results (Fig. 5) show that the 3' subunit of surface AChRs derived from T-myotubes, like those from wild-type myotubes, contain a mixture of endo H-sensitive and endo H-resistant forms of N-linked sugars. Thus the surface AChRs in T-cells have normal N-linked sugars.
Immunofluorescent Localization of Internal A C h R
The localization of the internal AChR in wild-type and Tmyotubes was investigated by immunofluorescence. Myotube cultures were incubated with unlabeled ct-BuTx to block surface AChRs, then fixed, permeabilized, and stained with rho-ot-BuTx as described in Materials and Methods. In parallel experiments cultures of myoblasts and myotubes were stained with Golgi or ER markers. A monoclonal antibody against BiP (Bole et al., 1986) was used for the ER, and both wheat germ agglutinin and a Golgi-specific monoclonal antibody (Allan and Kreis, 1986) for the Golgi apparatus. Similar results were obtained with both Golgi markers.
In both myoblasts and myotubes stained with anti-BiP (Fig. 6, A and B) , the ER forms an extensive network throughout the cell. Details of the network can be observed toward the edge of the myoblasts, where the cell is thinner. The pattern of anti-BiP staining is similar to that observed with lipid dye markers (Terasaki et al., 1984) , but differs somewhat from that observed with antibodies to membrane fractions derived from the rough ER (Louvard et al., 1982) . The most conspicuous difference is the bright perinuciear staining seen in the latter case. The difference in staining could occur because BiP is a luminal protein, rather than a membrane protein.
As observed by others, the Golgi pattern was strikingly different in myoblasts and myotubes (Tassin et al., 1985) (Fig. 6, C and D) . In myoblasts the Golgi apparatus was close to the nucleus and highly polar. A pattern of coarse dots was observed instead of the finely granular texture seen for the ER. In myotubes, evenly distributed but discontinuous Golgi staining was seen around each nucleus, and isolated dots of staining that seemed to link the Golgi apparatus from neighboring nuclei were distributed throughout the cytoplasm.
In wild-type myotubes the pattern of internal AChR staining showed characteristics of both ER and Golgi (Fig. 7) . The most prominent feature was the continuous perinuclear staining, which along with the diffuse staining throughout the cytoplasm, resembled that seen with ER markers. Coarsely dotted staining, like that of the Golgi apparatus was also seen, however. In double-label experiments, such dots were seen to be stained not only by rho-c~-BuTx, but also by the anti-Golgi antibody (Fig. 8) . In T-myotubes, the pattern of staining more closely resembled that of the ER. A bright, continuous perinuclear staining was seen, along with a diffuse, finely textured staining in the cytoplasm. No evidence was found for the coarse, dot-like pattern of the Golgi staining (Fig. 7) .
The distinction in rho-a-BuTx staining pattern in wildtype and T-cells was most clearly demonstrated in myoblasts. Although C2 myoblasts make little, if any, AChR when cultured under growth conditions, occasional mononucleated cells in fusion medium showed intense intracellular staining with rho-o~-BuTx. In wild-type cultures, this staining was near the nucleus and was distinctly polar, resembling that seen with Golgi markers; in T-cultures, in contrast, the staining was evenly distributed throughout the cytoplasm (Fig. 7) .
Localization of the Internal AChR by Subcellular Fractionation
As an additional method of localizing the internal pool of AChR in wild-type and T-cells, we used a sucrose gradient centrifugation procedure recently developed by Smith et al. (1987) that separates membranes derived from the Golgi apparatus and those from the ER. When applied to C2 myotubes cultures, these methods gave good separation between the Golgi marker enzyme, mannosidase II (Novikoff et al., 1983) , and a marker for the endoplasmic reticulum, glucose-6-phosphatase (Farquhar et al., 1974) (Fig. 6, B and D) ; another Golgi marker, UDP-galactose/N-acetylglucosamine galactosyltransferase, which is located in the trans-Golgi (Roth and Berger, 1982; Slot and Geuze, 1983) , sedimented to a density that was slightly higher than that of mannosidase II, in agreement with the results of Smith et al. (1987) . Although the gradients showed little or no contamination of Golgi fractions by the ER marker enzymes, there was a small peak of activity of both Golgi markers in the fractions containing ER markers. Surface membrane, identified by bound ~25I-ot-BuTx, was also found at approximately the same position in the gradient as glucose-6-phosphatase, the ER marker (data not shown). Thus the fractions containing ER are heterogeneous.
To examine the internal AChR, myotube cultures were incubated with unlabeled c~-BuTx to block surface receptors, then homogenized, and subjected to sucrose gradient centrifugation. Gradient fractions were analyzed for AChR by ~25I-u-BuTx binding, and for ER and Golgi markers as described in Materials and Methods. In homogenates from wild-type myotube cultures, the major peak of AChR was found in a position coincident with the ER marker, glucose-6-phosphatase (Fig. 9, a and b) . A smaller peak was also detected in the fractions containing the Golgi markers. Analysis of T-homogenates, however, showed that virtually all of the AChR was in the region of the gradient containing ER membranes (Fig. 9, c and d) . Little, if any, AChR was detected in the Golgi region. These experiments demonstrate clearly that the internal AChR in T-myotubes is not accumulated in the Golgi apparatus, and suggest that it may be retained in the ER.
Discussion
We have compared the properties and intracellular location of AChRs in wild-type C2 muscle cells and in T-, a C2 variant that accumulates AChR in an intracellular pool. The principal conclusion of our experiments is that in wild-type cells AChR is present both in the Golgi apparatus and in the ER; T-cells, in contrast, have reduced levels of AChR in the Golgi apparatus, and accumulate it in the ER. As shown elsewhere, inefficient transport from the ER to the Golgi apparatus is not a general defect in T-cells, but appears to be specific for the AChR. Thus T-myotubes have on their surface normal amounts of both the insulin receptor and the transferrin receptor and, after infection with influenza virus show normal transport of hemagglutinin protein to the surface (Gu et al., 1989 ; see also Fig. 4 legend) .
In normal myotubes •30% of the total AChR is intracellular, most of which serves as precursor for receptor on the surface (Devreotes et al., 1977; Gu et al., 1989) . Fambrough and Devreotes (1978) localized intracellular AChR to the Golgi, using ultrastructural methods. Recent pulse-labeling experiments, followed by subcellular fractionation, have shown that assembled AChR is also present in the ER (Smith et al., 1987) . Our results on wild-type C2 cells confirm both of these findings. Subcellular fractionation shows that most of the intracellular AChR is in fractions that contain membranes from the ER, but that a small peak of AChR is also in fractions containing Golgi membranes (Fig. 9) . Immunocytochemical experiments also show distinct staining for the AChR in the Golgi apparatus, as well as a more diffuse staining that is characteristic of the ER. Although more prominent in the Golgi than in the ER when viewed by immunocytochemistry, most of the intracellular AChR in C2 myotubes is probably in the ER. The subcellular fractionation results are consistent with this distribution, as is the finding that most of the internal AChR in wild-type cells contains only endo H-sensitive sugars (Gu, Y. and Z. W. Hall, unpublished observations) . In contrast to wild-type cells, most of the AChR in Tmyotubes is intracellular and does not serve as precursor for surface receptor (Gu et al., 1989) • Virtually all of the internal AChR appears to be in the ER. No AChR was observed in the Golgi fractions after subcellular fractionation (Fig. 9) ; the more sensitive immunocytochemical experiments also failed to detect AChR in the Golgi apparatus. In neither myoblasts nor myotubes was there any sign of the coarsely dotted staining pattern that is characteristic of the Golgi apparatus.
Analysis of N-linked glycosylation of the AChR subunits in the T-variant further indicated that they were accumulated in a pre-Golgi compartment. Both ~ and c5 subunits of the internal AChR in the T-variant lacked endo H-resistant oligosaccharides. Because the processing of N-linked sugars from high-mannose, endo H-sensitive forms to complex, endo H-resistant forms occurs in the Golgi apparatus (Kornfeld and Kornfeld, 1985) , AChR that is retained in the ER would necessarily lack endo H-resistant oligosaccharides. Accumulation of fully assembled AChR in the ER of Tmyotubes is consistent with the earlier finding by Smith et al. (1987) that the AChR is assembled there.
Our results are most consistent with AChR localization in the ER of T-myotubes, although the possibility that the receptor accumulates in a closely related compartment cannot be ruled out. The pattern of AChR staining in T-cells strongly resembles the pattern seen with anti-BiP, but is not identical with it. First, the AChR staining in T-cells was often more finely textured than anti-BiP staining. Second, the most prominent feature of the AChR staining, the intense perinuclear ring, was only occasionally seen with anti-BiP. Perinuclear ER is observed with the electron microscope, however, and other ER antibodies show strong perinuclear staining (Louvard et al., 1982) . Thus, an alternative explanation for the discrepancy is that the pattern seen with anti-BiP, which is a luminal protein, may not reflect the complete distribution of ER membranes.
What is the primary defect in T-cells? Although a number of genetic variants of mammalian cell lines that lack glycosylation processing enzymes have been described (Stanley, 1984; Kingsley et al., 1986) , the T-variant does not appear to be one of these• First, our experiments show no evidence for a general defect in glycosylation. Lectin sensitivity, and the processing of fibronectin and influenza virus HA protein appear to be unchanged in T-cells. Second, the T-phenotype cannot be reproduced in wild-type cells by inhibitors of enzymes in the glycosylation pathway (Gu, Y. and Z. W. Hall, unpublished results) .
A transport-defective mutant of CHO cells, gro29, has also been described by Tufaro et al. (1987) , but the properties of this variant are different from those of the T-variant of C2 cells• In gro29 cells, both oligosaccharide processing and export of viral protein is defective and protein accumulates in or near the Golgi apparatus. In T-cells, in contrast, viral protein is processed and transported to the surface with normal kinetics.
The defect in T-cells is not a general one, and may be specific to the AChR. The latter possibility raises the question of whether the defect is in the AChR itself or is in another protein. This question is unresolved by our experiments. A previous finding that the ct subunit is less rapidly degraded in T-than in wild-type cells (Gu, Y., manuscript submitted for publication) could be explained by a change in primary sequence of the a subunit, but could also have other explanations.
One of the most puzzling aspects of our experiments is that a minor proportion of the AChRs in T-cells is normally glycosylated (Fig. 5) and is transported to the surface with normal kinetics (Gu et al., 1989) . One possible explanation is that genes coding for the ct subunit on both chromosomes are expressed. It is possible that two copies of the a subunit are produced, one of which is mutated. If AChRs were assembled randomly, then only a minority of AChRs would have two correct ot subunits. Another possibility is that one of the subunits undergoes a conformational change before assembly such that incorrect folding, which is normally a rare event, becomes more frequent after a mutational alteration. The incorrectly folded subunit would then be assembled to form a defective AChR. We have shown that internal AChRs bind t~-BuTx and have a normal sedimentation coefficient (Gu et al., 1989) A final possibility arises from the observation that myotubes normally have a stable internal pool of AChRs that does not serve as precursor for surface receptor (Devreotes et al., 1977; Gu et al., 1989) . The function and location of this pool is unknown, but it could reflect the ability of the cell to regulate the proportion of AChR that is on its surface. If so, regulation in the T-variant might be altered so that receptor is preferentially retained. An intriguing feature of such a scheme would be the possibility of regulating transport from the ER to the Golgi apparatus to achieve different densities of surface AChR.
